News und Analysen

The cost of living is getting more and more expensive. This is because inflation steadily diminishes the value of the U.S. dollar over time, and the purchasing power of said dollar as a result.

One

If you look at the S&P 500, which is up more than 18% this year, or the Nasdaq Composite, which is up more than 34% in 2023, it appears the markets are booming. If you look specifically at biotech

Microsoft (NASDAQ: MSFT) stock has been under pressure since the technology giant released its fiscal 2023 fourth-quarter results (for the quarter ended June 30) on July 25, driven mainly by

Earnings season is here, with countless stocks on the move. The tech industry, in particular, is experiencing a lot of fluctuation as macroeconomic headwinds continue to burden many companies. 

If you're looking for stocks that can deliver better-than-average returns in the long run, you might want to consider these two biotechs: Exact Sciences (NASDAQ: EXAS) and Vertex Pharmaceuticals

There are many good reasons for investors to be attracted to Adobe's (NASDAQ: ADBE) business right now. Few other software specialists can claim anything approaching its market dominance in key

Apple (NASDAQ: AAPL) shares have skyrocketed roughly 140,000% since the company first went public in 1980. The tech giant has achieved the highest market cap in the world, surpassing $3 trillion

Alzheimer's patients could soon have more treatment options available. Biogen's Leqembi obtained approval from the U.S. Food and Drug Administration earlier this year, and another treatment from Eli

One of the great things about investing in stocks is that there is no need to have millions in the bank to get started. A relatively modest sum such as $1,000 can go a long way if invested shrewdly

Biotech giant Biogen (NASDAQ: BIIB) can't seem to keep its name out of the news. After a recent major approval for its Alzheimer's disease (AD) medicine Leqembi, the company just announced that it

Share prices of Apple (NASDAQ: AAPL) slipped nearly 5% after the company released fiscal 2023 third-quarter results (for the three months ended July 1) on Aug. 3. Apparently, investors pressed the

2023 has been generous so far to investors. Both the Nasdaq Composite and S&P 500 have been buoyant, returning 34% and 18% respectively. While the tech sector has enjoyed outsize returns so far this

Microsoft (NASDAQ: MSFT) should be a sure-fire Warren Buffett stock. It has a wide moat, excellent fundamentals, and investors have come to expect a great deal of consistency from the business over

Meta Platforms (NASDAQ: META) launched Threads last month, but the company has set its sights on a big growth opportunity with the metaverse. The company has made it clear it's not backing away from

PayPal (NASDAQ: PYPL) already looked like a cheap stock, and that was before it took a beating after earnings. In this video, I'll discuss the important numbers and why I like it even more now.

As one of the hottest and most-watched companies in the biopharmaceutical sector, Vertex Pharmaceuticals (NASDAQ: VRTX) has a unique mix of stability and growth potential that's attractive to a

Share prices of Apple (NASDAQ: AAPL) have tumbled 9% since Aug. 1 as a reaction to disappointing earnings results for the third quarter. The company did beat analyst estimates for earnings per share

There's little question that the advent of cloud computing was a game changer. The ability to store data in the cloud changed the technological landscape by providing secure access to

Earnings season is in full swing, with many of the world's valuable companies experiencing major stock fluctuations over the last week. Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) are two of the

Fool.com contributor Parkev Tatevosian reviews Apple's (NASDAQ: AAPL) second-quarter earnings and downgrades his recommendation for Apple stock.

*Stock prices used were the afternoon prices of Aug

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Okta is looking

Peloton (NASDAQ: PTON) stock rose 26.3% last month, according to S&P Global Market Intelligence. There was no major news that shifted expectations for the company's short-term revenue or earnings

Image source: The Motley Fool.

Datadog (NASDAQ: DDOG)Q2 2023 Earnings CallAug 08, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Datadog (NASDAQ: DDOG) were down 19% as of 12:19 p.m. ET on Tuesday. The software monitoring provider reported revenue growth of 25% year over year but issued cautious commentary about